With no biology degree and just $3,000, he designed a personalized mRNA vaccine in a world first. Moderna and Merck are ...
Luxna Biotech & Inabata ink license agreement for manufacture and sale of modified nucleic acid GuNA amidite: Osaka, Japan Monday, March 16, 2026, 09:00 Hrs [IST] Luxna Biotech Co ...
Stockhead on MSN
Racura secures green light for RC220 HARNESS-1 lung cancer trial
Study to test RC220 alongside standard-of-care osimertinib to prevent or delay treatment resistance. ... Read More The post Racura secures green light for RC220 HARNESS-1 lung cancer trial appeared ...
India, March 15 -- While some fear that artificial intelligence could lead to job losses and mass layoffs, for others it is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results